| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 1985;39:125-133
© 1985 The Society of Thoracic Surgeons
From the Departments of Surgery and Pathology, St. Louis University School of Medicine, St. Louis, MO
* Address reprint requests to Dr. Codd, St. Louis University Hospital, 1325 S Grand Blvd, St. Louis, MO 63104
Cardiac arrest was achieved in 84 patients using asanguineous cardioplegia and in 97 patients using cold blood potassium cardioplegia. The patient groups were similar in age, sex ratio, and preoperative risk factors. Other than the cardioplegic solution used, the conduct of each operation was identical. There were no differences in mean total pump time (118 minutes for the asanguineous cardioplegia group versus 117 minutes for the cold blood cardioplegia group) or cross-clamp time (73.5 versus 70 minutes, respectively). However, the blood cardioplegia group had a greater number of distal anastomoses per patient (3.9 versus 3.7; p < 0.05). Myocardial protection was assessed clinically and by serial electrocardiograms. Cellular integrity was determined by release of the myocardial isoenzyme of serum creatine kinase (CK-MB). Cellular morphology was studied in 6 randomly selected patients in each group by electron microscopic examination of left ventricular myocardial samples obtained before and after bypass. Three patients given blood cardioplegia and 5 given asanguineous cardioplegia required intraaortic balloon counterpulsation at termination of bypass. There were no ultrastructural changes in either group. Electrocardiographic changes (Minnesota code) occurred in 12 of 84 patients receiving asanguineous cardioplegia versus 12 of 97 patients receiving cold blood potassium cardioplegia. To maintain a satisfactory cardiac index (greater than 2.0 L/min/m2), 38 of 84 patients given asanguineous cardioplegia versus 25 of 97 patients given blood cardioplegia required inotropic support up to 24 hours postoperatively (p < 0.05). Infarct size determined from CK-MB release was significantly greater (p < 0.05) in patients given asanguineous cardioplegia (36.27 gm-equivalents) than in those given blood cardioplegia (26.7 gm-equivalents). These data suggest that blood cardioplegia provides better cellular protection during aortic cross-clamping in elective procedures.
This article has been cited by other articles:
|
|
 |
|
  A. A Albert, B. Arnrich, J. A Walter, W. M Hassanein, U. P Rosendahl, P. Gehle, F. Schon, and J. Ennker Hyperkalemic Blood versus Crystalloid Cardioplegia in Longer Clamping Times Asian Cardiovasc Thorac Ann, June 1, 2004; 12(2): 115 - 120. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. F. Ibrahim, G. E. Venn, C. P. Young, and D. J. Chambers A clinical comparative study between crystalloid and blood-based St Thomas' hospital cardioplegic solution Eur J Cardiothorac Surg, January 1, 1999; 15(1): 75 - 83. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Shanewise, A. S. Kosinski, J. A. Coto, and E. L. Jones Prospective, randomized trial comparing blood and oxygenated crystalloid cardioplegia in reoperative coronary artery bypass grafting J. Thorac. Cardiovasc. Surg., May 1, 1998; 115(5): 1166 - 1171. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Hendry, R. G. Masters, and A. Haspect Is there a place for cold crystalloid cardioplegia in the 1990s? Ann. Thorac. Surg., December 1, 1994; 58(6): 1690 - 1694. [Abstract] [PDF]
|
|
|
|
 |
|
 J. Golembiewski and N. Bourtsos Cardioplegia Solution Journal of Pharmacy Practice, August 1, 1993; 6(4): 182 - 189. [Abstract] [PDF]
|
|
|
|
|
|
H. B. Barner Blood cardioplegia: A review and comparison with crystalloid cardioplegia Ann. Thorac. Surg., December 1, 1991; 52(6): 1354 - 1367. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
